bioRxivGenomicsPreprint
Mutational and functional heterogeneity of homology-directed repair deficiency and clinical implications
Salome Jingchen ZhaoiD, Ching Chiek KohiD, Rachel BroughiD, Dragomir B. KrasteviD, Veenu Tripathi, Feifei SongiD, Sheyne S. A. ChoiiD, Daniella Black, Soraya Boushaki, Cherif BadjaiD, Rebecca A. DaggiD, Giuseppe RinaldiiD, Ping Jing ToongiD, Andrea DegasperiiD, Rohit PrakashiD, Scott ShooteriD, Jan CzarneckiiD, Yasin MemariiD, Helen Ruth DaviesiD, Stephen J. PettittiD, Madalena TarsounasiD, Maria JasiniD, Andrew N.J. TuttiD, André NussenzweigiD, Christopher J. LordiD, Serena Nik‐ZainaliD
Abstract
Homology-directed repair deficiency (HRd) encompasses mutations in multiple genes yet is treated clinically as a single entity. Here, through parallel analyses of isogenic knockouts of multiple HR pathway genes, integrating multi-omic analyses with genome-wide CRISPR-Cas9-dependency and resistance screens, we show that HRd is not a single entity but exists along a molecular and functional continuum. BRCA1, BRCA2, PALB2, RAD51C, and RAD51D mutants shared many HRd-associated mutational signatures, while RAD51B, BRIP1, CDK12 exhibited distinct genomic patterns. Functional heterogeneity was equally apparent: synthetic lethal interactions including CIP2A and a novel dependency on PRDX1 were penetrant across most HRd genotypes, whereas FANCM dependency was linked to HRd subtypes characterized by tandem duplications. PARPi resistance screens in distinct HRd contexts uncovered BRIP1 and RECQL5 as new BRCA2-specific resistance genes. HRd is thus a complex continuum, underscoring why modernizing the molecular taxonomy utilizing all genomic features available per patient is crucial to informing precision interventions.
- organism: human
- assay: whole-genome sequencing
- assay: CRISPR screen
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Beyond BRCA: Discovery of novel causes and consequences of homologous recombination deficiencies
Daniel James McGrail, Yang Li, … Nidhi Sahni·bioRxiv·Oct 1, 2022
- Pan-cancer landscape of homologous recombination deficiency
L. Nguyen, J. Martens, … E. Cuppen·bioRxiv·Jan 13, 2020
- Aberrant transcript usage induces homologous recombination deficiency and predicts therapeutic responses
Hyeon Gu Kang, Haeun Hwangbo, … Jung Kyoon Choi·Cancer ResearchPeer-reviewed·Oct 28, 2021
- Whole Genome Landscape Analysis of Homologous Recombination Deficiency in a Pan-Cancer Cohort
Majd Al Assaad, Kevin Hadi, … Juan Miguel Mosquera·medRxiv·Jun 28, 2024
- HRD-One: CLINICAL VALIDATION AND PERFORMANCE ASSESSMENT. Comparison between Myriad's myChoice(R), SOPHiA GENETICS SOPHiA Homologous Recombination Solution(R) and AmoyDx HRD Focus Panel(R)
Rodrigo Guarischi‐Sousa, José Eduardo Kroll, … Guilherme Lopes Yamamoto·medRxiv·Mar 28, 2023
- Breaking new ground into RAD51-BRC repeats interplay in Homologous Recombination
Francesco Rinaldi, Pedro Henrique Cavalcanti Franco, … Andrea Cavalli·Communications BiologyPeer-reviewed·Oct 30, 2026